Drug intelligence / Profile preview

Zinotic

Development stage
Unknown
Lead developer
Azurity Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Otic
01

Overview

Zinotic is a branded non‑antibiotic otic solution containing chloroxylenol, pramoxine hydrochloride, and zinc acetate, used primarily for the treatment of acute otitis externa and other superficial infections of the external ear. Chloroxylenol is a halogenated phenolic antiseptic with broad‑spectrum bactericidal and antifungal activity that treats the underlying infection, while pramoxine is a topical anesthetic that stabilizes neuronal membranes to provide rapid relief of ear pain and pruritus, and zinc acetate acts as a skin protectant that helps restore and shield the damaged epithelium of the ear canal.[1][3][7][9] This combination, developed and marketed by Arbor Pharmaceuticals as part of a pediatric‑focused ear‑care franchise, is administered as ear drops and is intended to simultaneously control infection, alleviate symptoms, and support healing of the ear canal without the use of systemic or topical antibiotics.[3][7][8][9]

Brand names
Zinotic
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Zinotic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinotic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call